C/ EBPβ Contributes to Cancer‐Induced Bone Pain by Inhibiting CD200 / CD200R1 in the Spinal Cord
CNS Neuroscience & Therapeutics · 2026
DOI: 10.1002/cns.70824 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Dan-Yang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: CCAAT-Enhancer-Binding Protein-beta, Spinal Cord, Cancer Pain, Antigens, CD. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Wuhan Talents Excellent Youth Program.
Abstract (Originalsprache)
Background
Advanced cancer patients still suffer from devastating bone pain, with less efficacious treatments. The spinal microglia activation and neuroinflammation are the pivotal pathological processes of cancer‐induced bone pain (CIBP). This study aims to explore whether c/EBPβ negatively regulates CD200R1 to induce microglia‐medicated neuroinflammation in the spinal cord of CIBP mice.
Methods
The CIBP mice model was constructed by intrafemoral injection of Lewis lung cancer cells to investigate the role of CD200/CD200R1 signaling and their upstream molecule CCAAT/enhancer binding protein β (c/EBPβ) in CIBP. Mechanical allodynia and thermal hyperalgesia were evaluated by von Frey filaments and hot plate, respectively. Adeno‐associated viruses were constructed to regulate the expression of CD200R1 and c/EBPβ. The protein level was assessed by western blotting, and microglia activation was detected by immunofluorescence.
Results
Our results showed that CD200/CD200R1 signaling was inhibited in the spinal cord of CIBP mice. Intrathecal injection of CD200R1 agonist CD200Fc effectively reversed the nociceptive behaviors in CIBP mice. Overexpression of CD200R1 could also effectively ameliorate the pain behaviors and spinal neuroinflammation in CIBP mice. Transcription factor c/EBPβ was upregulated in the spinal cord of CIBP mice. Knockdown of c/EBPβ effectively inhibited the microglia‐mediated neuroinflammation by restoring CD200R1 protein levels, alleviating pain behavior in CIBP mice. Conclusion c/EBPβ‐mediated suppression of the CD200/CD200R1 signaling pathway represents one potential mechanism in promoting microglial activation and neuroinflammation in the spinal cord of CIBP mice, which provides a potential therapeutic target for CIBP management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, Wuhan, China.
- Wuhan Clinical Research Center for Geriatric Anesthesia, Wuhan, China.
ORCID-Profile: Dai-Qiang Liu, Ya-Qun Zhou, Wei Mei
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Wuhan Talents Excellent Youth Program
- Key Research Project of Tongji Hospital
Zitieren
APA
Li, D. Y., Liu, L., Liu, D. Q., Zhang, L. Q., Zhou, Y. Q., & Mei, W. (2026). C/ EBPβ Contributes to Cancer‐Induced Bone Pain by Inhibiting CD200 / CD200R1 in the Spinal Cord. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70824
Vancouver
Li DY, Liu L, Liu DQ, Zhang LQ, Zhou YQ, Mei W. C/ EBPβ Contributes to Cancer‐Induced Bone Pain by Inhibiting CD200 / CD200R1 in the Spinal Cord. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70824
BibTeX
@article{Li2026,
author = {Li, Dan-Yang and Liu, Lin and Liu, Dai-Qiang and Zhang, Long-Qing and Zhou, Ya-Qun and Mei, Wei},
title = {C/ EBPβ Contributes to Cancer‐Induced Bone Pain by Inhibiting CD200 / CD200R1 in the Spinal Cord},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
doi = {10.1002/cns.70824}
}
EUVIMED